News

Neurovalens is studying the efficacy of a non-invasive electrical vestibular nerve stimulation (VeNS) device, the Modius Spero device, as a method of treating Post-Traumatic Stress Disorder (PTSD).

There are nearly one billion people worldwide who suffer from mental disorders. There is a stigma surrounding mental health making it difficult to speak up and seek help.

Covid 19 has been a huge impact on people's mental health all around the world. Within the first year of Covid-19, there has been a 25% increase in anxiety and depression worldwide.

These are the start-ups that most impressed Britain’s top entrepreneurs and investors in 2019. There was a technology theme to the selections, while several on our panel of small business champions picked companies, they claimed were tackling some of the world’s biggest problems by treating Alzheimer’s disease and broadening access to education.

A BELFAST technology firm developing a number of specialised medical devices has received its second major cash injection in a month.
Neurovalens has been boosted by £750,000 from the Growth Finance Fund to support the launch of a new sleep product in the USA later this year.

Belfast-based health tech company Neurovalens is set to create 22 new jobs with the development of a ground-breaking medical device.

Neurovalens, a global leader of neuro-technology products, is embarking on the development of a device for the treatment of obesity with £1m support from Invest NI. The technology is based on the neuro stimulation of specific areas of the brain responsible for influencing appetite and cravings.

The University of California recently awarded UC San Diego entrepreneur Jason McKeown for his wearable weight loss technology company Neurovalens, UC announced Monday.

A Northern Ireland firm that developed a headset aimed at helping weight loss is on the award shortlist at the tech world’s biggest event for innovators.

The product, Modius, claims to stimulate the part of the brain that controls fat storage and metabolism.